货号:GS40742
Tralokinumab is a fully human monoclonal antibody targeting interleukin-13 (IL-13), a key cytokine in type 2 inflammation. It binds to and neutralizes IL-13, blocking its interaction with IL-13 receptor complexes (IL-13Rα1 and IL-13Rα2). It is approved for the treatment of moderate-to-severe atopic dermatitis in adults, reducing skin inflammation, pruritus, and lesions.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物